Taken together with our previous data, these results demonstrate that the 6 identified subgroups of ER + breast tumors can be reproducibly identified in independent patient cohorts and provide a clinically relevant means of classifying ER + breast tumors. The gene discussed is ESR1; the disease is breast neoplasm.